Exchange: NYSE Sector: Basic Materials Industry: Specialty Chemicals
-8.53% $16.51
America/New_York / 3 jan 2024 @ 16:00
FUNDAMENTALS | |
---|---|
MarketCap: | 2 970.50 mill |
EPS: | 1.800 |
P/E: | 9.17 |
Earnings Date: | Feb 12, 2024 |
SharesOutstanding: | 179.92 mill |
Avg Daily Volume: | 20.42 mill |
RATING 2024-01-16 |
---|
S |
Strong Buy |
RATINGS | ||
---|---|---|
Rating CashFlow: | Strong Buy | |
Return On Equity: | Strong Buy | |
Return On Asset: | Strong Buy | |
DE: | Buy | |
P/E: | Strong Buy | |
Price To Book: | Buy |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
2/22 | 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt | n/a |
PE RATIO: COMPANY / SECTOR |
---|
0.17x |
Company: PE 9.17 | sector: PE 54.44 |
PE RATIO: COMPANY / INDUSTRY |
---|
0.27x |
Company: PE 9.17 | industry: PE 33.63 |
DISCOUNTED CASH FLOW VALUE |
---|
N/A |
N/A |
Expected Trading Range (DAY) |
---|
$ 3.74 - 6.50 ( +/- 26.88%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-04 | Daloia G Peter | Sell | 100 985 | Common Stock |
2024-01-04 | Daloia G Peter | Sell | 44 716 | Common Stock |
2024-01-04 | Brondeau Pierre R | Sell | 348 634 | Common Stock |
2024-01-04 | Brondeau Pierre R | Sell | 56 787 | Common Stock |
2024-01-04 | Pallash Robert C | Sell | 31 565 | Common Stock |
INSIDER POWER |
---|
-80.58 |
Last 100 transactions |
Buy: 562 768 | Sell: 2 276 104 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $16.51 (-8.53% ) |
Volume | 52.06 mill |
Avg. Vol. | 20.42 mill |
% of Avg. Vol | 254.90 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
Livent Corporation manufactures and sells performance lithium compounds primarily used in lithium-based batteries, specialty polymers, and chemical synthesis applications in North America, Latin America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers lithium compounds for use in applications that have specific performance requirements, including battery-grade lithium hydroxide for use in high performance lithium-ion batteries; and butyllithium, which is used in the production of polymers and pharmaceutical products, as well as a range of specialty lithium compounds, including high purity lithium metal, which is used in non-rechargeable batteries and the production of lightweight materials for aerospace applications. It also provides lithium phosphate, pharmaceutical-grade lithium carbonate, high purity lithium chloride, and specialty organics; and lithium carbonate and lithium chloride for use as feedstock in the process of producing performance lithium compounds. The company was incorporated in 2018 and is headquartered in Philadelphia, Pennsylvania.